Company Filing History:
Years Active: 2005-2017
Title: The Innovations of Hans-Peter Biemann
Introduction
Hans-Peter Biemann is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of TNF-α signaling. With a total of 5 patents to his name, Biemann's work has had a substantial impact on medical treatments for various conditions.
Latest Patents
Biemann's latest patents focus on modulators of TNF-α signaling. The present invention provides compounds that act as modulators of TNF-α signaling and methods for their use in treating patients with TNF-α mediated conditions. These compounds can be represented by specific structural formulas, showcasing the innovative nature of his work.
Career Highlights
Throughout his career, Biemann has been associated with Genzyme Corporation, where he has contributed to groundbreaking research and development. His expertise in biotechnology has positioned him as a key figure in the industry.
Collaborations
Biemann has collaborated with notable colleagues, including Scott F Sneddon and John L Kane, Jr. These partnerships have further enhanced the scope and impact of his inventions.
Conclusion
Hans-Peter Biemann's contributions to biotechnology, particularly through his patents on TNF-α signaling, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.